Literature DB >> 12914389

Combined treatments in gastric cancer: radiotherapy.

Vincenzo Valentini1, Francesco Cellini, Rolando M D'Angelillo.   

Abstract

In the past decades radiation oncologists have not had a major interest in the treatment of gastric cancer. The concern on major toxicity related to an extended irradiation of the upper abdomen limited the experience in the treatment of this disease; therefore few data were available to evaluate any advantage of the use of radiation therapy. The results of the Gastrointestinal Intergroup Study promoted a new interest in the irradiation of gastric cancer. The analysis of the outcomes of the Intergroup Study supported the role of locoregional control in promoting better survival for patients treated with adjuvant chemoradiation vs resected patients (81% vs 71%). The studies reported in the last years on the use of radiotherapy in gastric carcinoma are reviewed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914389

Source DB:  PubMed          Journal:  Suppl Tumori        ISSN: 2283-5423


  2 in total

1.  Effects of mifepristone on proliferation of human gastric adenocarcinoma cell line SGC-7901 in vitro.

Authors:  Da-Qiang Li; Zhi-Biao Wang; Jin Bai; Jie Zhao; Yuan Wang; Kai Hu; Yong-Hong Du
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

2.  Are the indications for postoperative radiotherapy in the NCCN guidelines for patients with gastric adenocarcinoma too broad? A study based on the SEER database.

Authors:  Ze-Ning Huang; Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ju-Li Lin; Hua-Long Zheng; Chang-Ming Huang
Journal:  BMC Cancer       Date:  2018-11-03       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.